rs11168036: Genetic Associations with Alzheimer's and Longevity
The genetic variant rs11168036 is a common single nucleotide polymorphism (SNP) located in an intergenic region on chromosome 5. It has been identified in research as a shared genetic signal potentially linked to both Alzheimer's disease risk and human longevity.
What each genotype means
Potential longevity-associated profile
This genotype has been identified in research as a shared genetic signal between human longevity and Alzheimer's disease risk. Because this variant is intergenic and its functional impact is still being studied, it is not a diagnostic marker for either condition. Please consult with a healthcare professional if you have concerns about your long-term cognitive health.
This is a common genotype found across diverse global populations.
Potential longevity-associated profile
This genotype has been identified in research as a shared genetic signal between human longevity and Alzheimer's disease risk. Because this variant is intergenic and its functional impact is still being studied, it is not a diagnostic marker for either condition. Please consult with a healthcare professional if you have concerns about your long-term cognitive health.
This is a common genotype found across diverse global populations.
Potential longevity-associated profile
This genotype has been identified in research as a shared genetic signal between human longevity and Alzheimer's disease risk. Because this variant is intergenic and its functional impact is still being studied, it is not a diagnostic marker for either condition. Please consult with a healthcare professional if you have concerns about your long-term cognitive health.
This is a common genotype found across diverse global populations.
What is rs11168036?
A single nucleotide polymorphism, or SNP, is a variation at a single position in a DNA sequence among individuals. The variant rs11168036 is located on chromosome 5 at position 140,327,854 (GRCh38). Because it is situated in an intergenic region—the space between genes—it does not code for a protein directly. Instead, researchers often investigate such variants to see if they act as regulatory elements that influence how nearby genes are turned on or off. In the case of rs11168036, it is often mapped in proximity to the PFDN1 and HBEGF genes. Understanding these non-coding variants is a major focus of modern genomics, as they may help explain the complex genetic architecture underlying common, late-onset health conditions.
The Role of Nearby Genes
While rs11168036 is intergenic, it is frequently studied alongside the PFDN1 and HBEGF genes. PFDN1 (Prefoldin Subunit 1) is involved in protein folding, a process critical for maintaining cellular health and preventing the accumulation of misfolded proteins, which is a hallmark of several neurodegenerative conditions. HBEGF (Heparin-Binding EGF-Like Growth Factor) plays a role in cell proliferation, differentiation, and wound healing. Because these genes are involved in fundamental biological processes like protein homeostasis and growth signaling, researchers hypothesize that regulatory changes in this genomic region could theoretically influence susceptibility to diseases characterized by cellular stress or aging. However, the exact functional mechanism by which this specific SNP might influence these genes remains a subject of ongoing scientific investigation.
Research and Evidence Strength
The evidence linking rs11168036 to Alzheimer's disease is considered moderate and is primarily derived from genome-wide association studies (GWAS). These studies look for statistical correlations between specific genetic markers and health traits across large populations. Research has identified this variant as a shared genetic signal between Alzheimer's disease risk and longevity. While these statistical associations are significant in large datasets, they do not imply a direct cause-and-effect relationship. The biological impact of this variant is complex, and it is likely one of many genetic and environmental factors that contribute to an individual's overall risk profile. Because the findings are based on population-level data, they cannot be used to predict an individual's health outcome or diagnose a specific condition.
Population Frequency
The rs11168036 variant is classified as a common SNP, meaning it is found frequently across diverse human populations. Large-scale genomic databases like gnomAD provide data on the frequency of such variants, showing that they are widely distributed rather than being restricted to specific ancestral groups. Because it is common, most people carry at least one copy of the variant. Its widespread presence suggests that it is a normal part of human genetic diversity. When interpreting such data, it is important to remember that 'common' does not mean 'harmful' or 'beneficial'; it simply describes how often the variant appears in the general population. Researchers use this frequency data to distinguish between rare, potentially pathogenic mutations and common variations that contribute to the natural spectrum of human traits.
What This Information Means for You
It is important to understand that genetic associations are not medical diagnoses. Finding that you carry a specific genotype for rs11168036 does not mean you will develop Alzheimer's disease or experience a specific longevity outcome. These associations are based on statistical trends observed in large groups of people and do not account for the many other genetic, lifestyle, and environmental factors that influence health. You cannot use this information to make medical decisions or predict your future health. If you have concerns about your risk for Alzheimer's disease or other health conditions, the most effective approach is to consult with a healthcare professional or a genetic counselor. They can provide personalized guidance based on your family history, clinical symptoms, and established medical screening protocols.
How common is this variant?
The rs11168036 variant is a common polymorphism found across diverse global populations, with its specific allele frequencies varying slightly by ancestry.
Frequently asked questions
Is rs11168036 a diagnostic test for Alzheimer's?
No, rs11168036 is not a diagnostic test. It is a genetic marker associated with statistical risk in population studies, not a clinical tool for diagnosing Alzheimer's disease in individuals.
Can I change my risk based on my rs11168036 genotype?
Genetic variants are fixed at birth. While you cannot change your genotype, you can focus on modifiable lifestyle factors—such as diet, exercise, and cognitive engagement—that are known to support brain health.
Why is this variant linked to both Alzheimer's and longevity?
Researchers study shared genetic signals to understand the biological overlap between aging and disease. The link suggests that some genetic factors influencing disease susceptibility may also play a role in the broader processes of human aging.
Should I be worried if I have the 'risk' allele?
No. Most common genetic variants have only a very small effect on overall disease risk. Having a specific allele does not determine your health outcome, as many other factors contribute to your risk profile.
Sources & further reading
Educational information only, last refreshed 10/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11168036?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This SNP acts as an intermediate allele tag for the C9orf72 repeat expansion, which is linked to both ALS risk and longevity outcomes.
This variant in the CDKN2B-AS1 long noncoding RNA gene is associated with extreme longevity in genome-wide association studies.
A variant in the ALOX5 gene associated with potential modulation of inflammatory responses to dietary factors.
This SNP is linked to cardiovascular disease prevention strategies and personalized nutritional approaches.
This polymorphism in the arachidonate 5-lipoxygenase gene is investigated for its potential influence on cardiovascular disease risk and dietary response.
A variant in the cyclooxygenase-2 gene that may influence individual susceptibility to inflammatory conditions and dietary modulation.
